Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Trulieve Cannabis Corp. (OTC: TCNNF) resulting from allegations that Trulieve may have issued materially misleading business information to the investing public.
On December 17, 2019, Grizzly Research issued an article reporting that most of the Company’s cultivation space comes from “hoop houses that produce low quality output,” that there were extensive ties between Trulieve and ongoing FBI investigations into corruption, that the Company’s initial license approval “stinks of corruption,” and that the Company engaged in several undisclosed related party transactions.
As a result of this news, Trulieve’s share price fell $1.51 or over 12.6% to close at $10.40 on December 17, 2019.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Trulieve investors. If you purchased shares of Trulieve please visit the firm’s website at http://www.rosenlegal.com/cases-register-1745.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.